Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
TPCN1 - Sunitinib effect on renal cancer xenograft tumors
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TPCN1 - Fibroblast response to coculture with basal breast cancer cells
TPCN1 - Rapamycin-resistant diffuse large B-cell lymphoma cell lines
TPCN1 - Diabetic ischemic heart failure patients: non-infarcted left ventricle
TPCN1 - Interferon-gamma effect on peripheral blood monocyte-derived dendritic cells
TPCN1 - Transcription factor Pax5 overexpression in Hodgkin lymphoma cell line L428
TPCN1 - Modified natural and stimulated in vitro fertilization cycles: cumulus cells
TPCN1 - HIV envelope protein gp120 effect on activated B cells from healthy donors: time course
TPCN1 - Single nucleotide polymorphism rs1333049 from the 9p21.3 coronary artery disease risk locus: normal heart
TPCN1 - AP1510, TGFα or heregulin ligand effect on MCF10 mammary epithelial cells expressing HER2-FKBP-HA chimeric receptors
TPCN1 - Protein tyrosine kinase PTK7 knockdown effect on lung adenocarcinoma cell lines
TPCN1 - Sporadic medulloblastomas
TPCN1 - Anaplastic thyroid carcinomas: thyroid biopsies
TPCN1 - Long-term octreotide treatment of neuroendocrine tumor cell line CNDT2.5
TPCN1 - Barrett esophagus: endoscopic biopsies
TPCN1 - Interleukin-3 effect on acute myeloid leukemia patient mononuclear cells: time course
TPCN1 - Facioscapulohumeral muscular dystrophy: bicep and deltoid muscles
TPCN1 - Dietary fatty acid composition effect on vastus lateralis muscle
TPCN1 - Hypoxia effect on von Hippel Lindau-overexpressing renal cell carcinoma cells
TPCN1 - Acute myeloid leukemia cell line Kasumi-1 response to dasatinib treatment and withdrawal
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on